drugset / Trial / NCT02065401
Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt)
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to compare the pharmacokinetic profiles of deferitazole after administration of granule and tablet formulations of a deferitazole disodium salt to a capsule formulation of deferitazole magnesium hydroxide salt (reference formulation) in healthy adult subjects.
Timeline
- Start
- 2014-02-28
- Primary completion
- 2014-03-19
- Completion
- 2014-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPD602 | Unknown | 1500 mg | Oral |
| Subject | SPD602 | Unknown | 2400 mg | Oral |
Indications
No indication recorded.